当前位置:首页 - 行情中心 - 悦康药业(688658) - 财务分析

悦康药业

(688658)

  

流通市值:72.41亿  总市值:72.41亿
流通股本:4.50亿   总股本:4.50亿

悦康药业(688658)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至第三季度实现净利润2.08亿元,每股收益0.47元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至第三季度最新股东权益367191.03万元,未分配利润50627.76万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至第三季度最新总资产600371.02万元,负债233179.99万元。

利润表
报告期2024-09-302024-06-302024-03-312023-12-31
营业总收入2,991,795,632.651,950,036,435.86967,900,022.684,196,300,749.57
营业总成本2,730,072,277.721,804,764,081.76904,066,984.173,960,329,636.78
营业利润254,972,423.52144,696,462.1480,364,945.02231,752,750.82
利润总额248,270,396.38138,539,419.679,115,648.13223,268,263.96
净利润208,200,539.69117,945,793.0769,124,285.22187,494,090.53
其他综合收益----
综合收益总额208,200,539.69117,945,793.0769,124,285.22187,494,090.53
资产负债表
报告期2024-09-302024-06-302024-03-312023-12-31
流动资产合计3,426,215,958.443,315,161,810.453,625,964,182.863,424,676,946.88
非流动资产合计2,577,494,244.252,540,905,542.222,483,073,207.262,486,599,454.92
资产总计6,003,710,202.695,856,067,352.676,109,037,390.125,911,276,401.8
流动负债合计1,762,693,023.211,822,644,802.072,035,140,002.432,136,632,435.56
非流动负债合计569,106,848.05451,766,965.79428,934,780.76177,004,400.11
负债合计2,331,799,871.262,274,411,767.862,464,074,783.192,313,636,835.67
归属于母公司股东权益合计3,663,638,001.193,572,466,451.13,635,346,891.713,587,842,712.3
股东权益合计3,671,910,331.433,581,655,584.813,644,962,606.933,597,639,566.13
负债和股东权益合计6,003,710,202.695,856,067,352.676,109,037,390.125,911,276,401.8
现金流量表
报告期2024-09-302024-06-302024-03-312023-12-31
经营活动现金流入小计3,326,912,990.092,186,967,530.061,099,895,626.674,876,328,058.64
经营活动现金流出小计2,896,427,143.691,945,454,939.75953,764,729.44,090,836,476.1
经营活动产生的现金流量净额430,485,846.4241,512,590.31146,130,897.27785,491,582.54
投资活动现金流入小计1,315,297.18467,752.05124,802.0510,930,936.14
投资活动现金流出小计321,426,486.01192,676,399.1190,961,646.48512,977,682.58
投资活动产生的现金流量净额-320,111,188.83-192,208,647.06-90,836,844.43-502,046,746.44
筹资活动现金流入小计523,673,304.58383,229,128.7281,730,725387,292,022
筹资活动现金流出小计526,928,672.15395,299,271.1792,464,155.54819,484,069.68
筹资活动产生的现金流量净额-3,255,367.57-12,070,142.47189,266,569.46-432,192,047.68
汇率变动对现金及现金等价物的影响502,565.99572,913.37120,751.253,935,520.17
现金及现金等价物净增加额107,621,855.9937,806,714.15244,681,373.55-144,811,691.41
期末现金及现金等价物余额1,481,155,046.281,411,339,904.441,618,214,563.841,373,533,190.29
最新报告期:2024-11-07
研究机构分析师预测每股收益(元)更新日
2024年2025年2026年
国盛证券张金洋,胡偌碧0.670.871.022024-11-07
开源证券余汝意0.710.911.222024-10-31
TOP↑